Ibd Remedy
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2018 | 27,018 | 9,310 | 17,708 | 69.6 | — |
| 2019 | 25,000 | 4,788 | 20,212 | 186.1 | — |
| 2020 | 0 | 3,972 | −3,972 | 212.3 | — |
| 2021 | 0 | 2,656 | −2,656 | 305.5 | — |
| 2022 | 0 | 3,195 | −3,195 | 241.9 | — |
| 2023 | 0 | 1,438 | −1,438 | 525.5 | — |
In its most recent public year (2023), this organization spent $1,438 more than it brought in. Its reserves stood at about 525.5 months of spending, up from 69.6 in 2018.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Ibd Remedy's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works